Louise A Koelmeyer, Katrina Gaitatzis, Mary S Dietrich, Chirag S Shah, John Boyages, Sarah A McLaughlin, Bret Taback, Deonni P Stolldorf, Elisabeth Elder, T Michael Hughes, James R French, Nicholas Ngui, Jeremy M Hsu, Andrew Moore, Sheila H Ridner
BACKGROUND: To evaluate risk factors (treatment-related, comorbidities, and lifestyle) for breast cancer-related lymphedema (BCRL) within the context of a Prospective Surveillance and Early Intervention (PSEI) model of care for subclinical BCRL. METHODS: The parent randomized clinical trial assigned patients newly diagnosed with breast cancer to PSEI with either bioimpedance spectroscopy (BIS) or tape measurement (TM). Surgical, systemic and radiation treatments, comorbidities, and lifestyle factors were recorded...
September 15, 2022: Cancer